Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Keskin DB"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cieri N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Hookeri N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Stromhaug K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Li L; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Keating J; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Díaz-Fernández P; Department of Immunology, Instituto de Investigación Sanitaria Princesa (IIS-IP), Hospital Universitario de La Princesa, Madrid, Spain., Gómez-García de Soria V; Department of Hematology, Instituto de Investigación Sanitaria Princesa (IIS-IP), Hospital Universitario de La Princesa, Madrid, Spain., Stevens J; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Kfuri-Rubens R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Shao Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Kooshesh KA; Harvard Medical School, Boston, MA, USA., Powell K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ji H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hernandez GM; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Abelin J; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Klaeger S; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Department of Proteomic and Genomic Technologies, Genentech Inc, South San Francisco, CA, USA., Forman C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Clauser KR; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Sarkizova S; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Braun DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Lane WJ; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Kean LS; Harvard Medical School, Boston, MA, USA.; Division Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA., Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA., Carr SA; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Computer Science, Metropolitan College, Boston University, Boston, MA, USA.; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Muñoz-Calleja C; Department of Immunology, Instituto de Investigación Sanitaria Princesa (IIS-IP), Hospital Universitario de La Princesa, Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Stewart C; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Getz G; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA. catherine_wu@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. catherine_wu@dfci.harvard.edu.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2024 Aug 21. Date of Electronic Publication: 2024 Aug 21.
Autor:
Zeng YC; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Young OJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Harvard-Massachusetts Institute of Technology (MIT) Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA., Wintersinger CM; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Anastassacos FM; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., MacDonald JI; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA., Isinelli G; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Drug and Health Sciences, University of Catania, Catania, Italy., Dellacherie MO; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA., Sobral M; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA., Bai H; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA., Graveline AR; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA., Vernet A; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA., Sanchez M; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA., Mulligan K; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Choi Y; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea., Ferrante TC; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA., Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Fell GG; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Mooney DJ; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA., Kwon IC; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea., Ryu JH; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. jhryu@kist.re.kr.; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea. jhryu@kist.re.kr., Shih WM; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. william_shih@dfci.harvard.edu.; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA. william_shih@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. william_shih@dfci.harvard.edu.
Publikováno v:
Nature nanotechnology [Nat Nanotechnol] 2024 Jul; Vol. 19 (7), pp. 1055-1065. Date of Electronic Publication: 2024 Mar 15.